148 related articles for article (PubMed ID: 30943862)
1. Efficacy of dendritic cell-based immunotherapy produced from cord blood in vitro and in a humanized NSG mouse cancer model.
Liu G; Fan X; Cai Y; Fu Z; Gao F; Dong J; Li K; Cai J
Immunotherapy; 2019 May; 11(7):599-616. PubMed ID: 30943862
[TBL] [Abstract][Full Text] [Related]
2. Effects of dendritic cells from cord blood CD34+ cells on human hepatocarcinoma cell line BEL-7402 in vitro and in SCID mice.
Su ZJ; Chen HB; Zhang JK; Xu L
World J Gastroenterol; 2005 Apr; 11(16):2502-7. PubMed ID: 15832426
[TBL] [Abstract][Full Text] [Related]
3. Human CD141
Lee YS; O'Brien LJ; Walpole CM; Pearson FE; Leal-Rojas IM; Masterman KA; Atkinson V; Barbour A; Radford KJ
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737342
[TBL] [Abstract][Full Text] [Related]
4. Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy.
Kumar J; Kale V; Limaye L
Stem Cell Res Ther; 2015 Sep; 6():184. PubMed ID: 26407613
[TBL] [Abstract][Full Text] [Related]
5. Induction of antitumor cytotoxic activity using CD34+ cord blood cell-derived and irradiated tumor cell-primed dendritic cells.
Fujii S; Fujimoto K; Osato M; Matsui K; Takatsuki K; Kawakita M
Int J Hematol; 1998 Aug; 68(2):169-82. PubMed ID: 9803675
[TBL] [Abstract][Full Text] [Related]
6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion does not alter the capacity of umbilical cord blood CD34+ cells to generate functional T lymphocytes and dendritic cells.
Kobari L; Giarratana MC; Gluckman JC; Douay L; Rosenzwajg M
Stem Cells; 2006 Sep; 24(9):2150-7. PubMed ID: 16946001
[TBL] [Abstract][Full Text] [Related]
8. The study on specific umbilical blood Dc vaccine for Beige nude mice loaded human colorectal carcinoma to induce anti-tumor immunity.
Fu ZX; Han JS; Liu F; Zhao ZL; Li DB; Shi L; Dong JT; Zhou Y; Cai JH
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2364-2371. PubMed ID: 28617554
[TBL] [Abstract][Full Text] [Related]
9. AAV-Vectored Fms-Related Tyrosine Kinase 3 Ligand Inhibits CD34
Ling L; Tang X; Huang X; Li J; Wang H; Chen Z
J Neuroimmune Pharmacol; 2018 Dec; 13(4):541-550. PubMed ID: 30377944
[TBL] [Abstract][Full Text] [Related]
10. Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells.
Wu L; Zhang H; Jiang Y; Gallo RC; Cheng H
Proc Natl Acad Sci U S A; 2018 May; 115(19):E4453-E4462. PubMed ID: 29674449
[TBL] [Abstract][Full Text] [Related]
11. Skin-Grafting and Dendritic Cell "Boosted" Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines.
Zeng B; Moi D; Tolley L; Molotkov N; Frazer IH; Perry C; Dolcetti R; Mazzieri R; Cruz JLG
Cells; 2023 Aug; 12(16):. PubMed ID: 37626903
[TBL] [Abstract][Full Text] [Related]
12. Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells.
Dilioglou S; Cruse JM; Lewis RE
Exp Mol Pathol; 2003 Aug; 75(1):18-33. PubMed ID: 12834622
[TBL] [Abstract][Full Text] [Related]
13. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
[TBL] [Abstract][Full Text] [Related]
14. CD34+ cord blood DC-induced antitumor lymphoid cells have efficacy in a murine xenograft model of human ALL.
Cullup H; Hsu AK; Kassianos AJ; McDonald K; Radford KJ; Rice AM
J Immunother; 2011 May; 34(4):362-71. PubMed ID: 21499125
[TBL] [Abstract][Full Text] [Related]
15. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
[TBL] [Abstract][Full Text] [Related]
16. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.
Sato K; Nagayama H; Takahashi TA
Cryobiology; 1998 Dec; 37(4):362-71. PubMed ID: 9917353
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses.
Dashti A; Ebrahimi M; Hadjati J; Memarnejadian A; Moazzeni SM
Cancer Lett; 2016 Apr; 374(1):175-185. PubMed ID: 26803056
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
[TBL] [Abstract][Full Text] [Related]
20. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.
Qiu J; Lil GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W; Song HP
Hepatogastroenterology; 2007; 54(75):681-7. PubMed ID: 17591041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
